Stocks in the News: $HALB https://thestreetrepo
Post# of 630
https://thestreetreports.com/stocks-in-the-ne...dtii-gbxi/
Halberd Corporation (OTC: HALB) – On May 9, the company said that the researchers of its collaboration partner Mississippi State University College of Veterinary Medicine had been awarded the approval for its test protocol.
Additionally, it was also announced that the test subjects had also been ordered. The testing would be related to the development of the nasal spray from Halberd which is meant for tackling the effects of brain trauma. The preliminary data gathering and the parameter qualifications would begin early next week.